| 1 |
Richeldi L，Collard HR，Jones MG.Idiopathic pulmonary fibrosis［J］.Lancet，2017，389（10082）： 1941-1952.
|
| 2 |
Hewlett JC，Kropski JA，Blackwell TS.Idiopathic pulmonary fibrosis：Epithelial-mesenchymal interactions and emerging therapeutic targets［J］.J Int Soc Matrix Biol，2018，71-72： 112-127.
|
| 3 |
Zhang E，Luo S，Tan X，et al.Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent ［ J ］.Biomaterials，2014，35（2）： 771-778.
|
| 4 |
Meng X，Yu Z，Xu W，et al.Control of fibrosis and hypertrophic scar formation via glycolysis regulation with IR780［J］.Burns ＆trauma，2022，10： tkac015.
|
| 5 |
Li J，Shen C，Qiu H，et al.Intravesical IR-780 instillation prevents radiation cystitis by protecting urothelial integrity［J］.Neurourol Urodynam，2023，42（1）： 40-48.
|
| 6 |
Luo M，Chen L，Zheng J，et al.Mitigation of radiation-induced pulmonary fibrosis by small-molecule dye IR-780［J］.Free Rad Biol Med，2021，164： 417-428.
|
| 7 |
Kang YP，Lee SB，Lee JM，et al.Metabolic profiling regarding pathogenesis of idiopathic pulmonary fibrosis［J］.J Proteome Res，2016，15（5）： 1717-1724.
|
| 8 |
Xie N，Tan Z，Banerjee S，et al.Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis［J］.Am J Respir Crit Care Med，2015，192（12）： 1462-1474.
|
| 9 |
Lemons JM，Feng XJ，Bennett BD，et al.Quiescent fibroblasts exhibit high metabolic activity［J］.PLoS biology，2010，8（10）：e1000514.
|
| 10 |
Kottmann RM，Kulkarni AA，Smolnycki KA，et al.Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-beta［J］.Am J Respir Crit Care Med，2012，186（8）： 740-751.
|
| 11 |
Goodwin J，Choi H，Hsieh MH，et al.Targeting hypoxia-inducible factor-1alpha/pyruvate dehydrogenase kinase 1 axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosis［J］.Am J Respir Cell Molecul Biol，2018，58（2）： 216-231.
|
| 12 |
Lederer DJ，Martinez FJ.Idiopathic pulmonary fibrosis［J］.New Engl J Med，2018，379（8）： 797-798.
|
| 13 |
Diamantopoulos A，Wright E，Vlahopoulou K，et al.The burden of illness of idiopathic pulmonary fibrosis： a comprehensive evidence review［J］.Pharmaco Economics，2018，36（7）： 779-807.
|
| 14 |
Raghu G，Rochwerg B，Zhang Y，et al.An official ATS/ERS/JRS/ALAT clinical practice guideline： Treatment of idiopathic pulmonary fibrosis.An update of the 2011 clinical practice guideline［J］.Am J Respir Crit Care Med，2015，192（2）： e3-19.
|
| 15 |
Fridlender ZG，Cohen PY，Golan O，et al.Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis［J］.European Respir J，2007，30（2）： 205-213.
|
| 16 |
Conte E，Gili E，Fagone E，et al.Effect of pirfenidone on proliferation，TGF-beta-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts ［ J］.European J Pharmaceut Sci，2014，58： 13-19.
|
| 17 |
Katzen J，Beers MF.Contributions of alveolar epithelial cell quality control to pulmonary fibrosis［J］.J Clin Invest，2020，130（10）：5088-5099.
|
| 18 |
Bargagli E，Refini RM，d′Alessandro M，et al.Metabolic dysregulation in idiopathic pulmonary fibrosis［J］.Int J Molecul Sci，2020，21（16）： doi：10.3390/ijms21165663.
|
| 19 |
Michaeloudes C，Bhavsar PK，Mumby S，et al.Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases［J］.J Innate Immun，2020，12（1）： 31-46.
|
| 20 |
Liu X，Zhang L，Zhang W.Metabolic reprogramming：A novel metabolic model for pulmonary hypertension［J］.Front Cardiovascul Med，2022，9： 957524.
|
| 21 |
Chung KP，Hsu CL，Fan LC，et al.Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis［J］.Nature Communicat，2019，10（1）： 3390.
|
| 22 |
Chu SG，Villalba JA，Liang X，et al.Palmitic acid-rich high-fat diet exacerbates experimental pulmonary fibrosis by modulating endoplasmic reticulum stress［J］.Am J Respirat Cell Molecul Biol，2019，61（6）： 737-746.
|
| 23 |
Koudelka A，Cechova V，Rojas M，et al.Fatty acid nitroalkene reversal of established lung fibrosis［J］.Redox Biol，2022，50：102226.
|
| 24 |
Shi X，Chen Y，Liu Q，et al.LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis［J］.Clin Translat Med，2022，12（1）： e711.
|
| 25 |
Wang L，Yuan H，Li W，et al.ACSS3 regulates the metabolic homeostasis of epithelial cells and alleviates pulmonary fibrosis［J］.Biochim Biophys Acta Molecul Basis Dis，2024，1870 （2）：166960.
|
| 26 |
Selvarajah B，Azuelos I，Plate M，et al.mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-beta（1）-induced collagen biosynthesis［J］.Sci Signal，2019，12（582）： doi：10.1126/scisignal.aav3048.
|
| 27 |
Xu Q，Cheng D，Li G，et al.CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner［J］.Int J Biolog Sci，2021，17（9）： 2294-2307.
|
| 28 |
Inoki K，Haneda M，Maeda S，et al.TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells［J］.Kidney Int，1999，55（5）： 1704-1712.
|
| 29 |
Hertenstein H，McMullen E，Weiler A，et al.Starvation-induced regulation of carbohydrate transport at the blood-brain barrier is TGF-beta-signaling dependent［J］.Elife，2021，10： doi：10.7554/eLife.62503.
|
| 30 |
Andrianifahanana M，Hernandez DM，Yin X，et al.Profibrotic upregulation of glucose transporter 1 by TGF-beta involves activation of MEK and mammalian target of rapamycin complex 2 pathways［J］.FASEB J，2016，30（11）： 3733-3744.
|